ADAMTS8 and lung adenocarcinoma: Dunn et al. [20] also reported abnormal hypermethylation of ADAMTS8 in 67% of lung adenocarcinomas and 50% of lung squamous cell carcinomas, but the methylation status of ADAMTS8 promoter did not correlate with age, differentiation, or TNM status.